Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
Nieuwe neuroprotectieve behandeling 2-IB veilig bij ischemische beroerte na trombectomie
dec 2025 | Neuro-vasculair